Skip to main content
Caplight Logo









GI Longevity

GI Longevity

Private
South KoreaHealthcare & Life Scienceshttps://gi-longevity.com/kr/index.php

Last Round

Corporate Funding

Nov 20, 2023

Total Funding Raised

$30.78M

Company Overview

GI Longevity is a biotechnology company that develops microbiome-based anti-aging therapies and health functional foods.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Sports & Fitness

Business Model

B2C

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

microbiome therapeuticsanti-aginglongevity sciencehealth functional foodbiotech R&Dbioinformaticsclinical trialsdrug discoverymulti-omicsbiohackingsupplementshealthy agingnutraceuticals

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GI Longevity Comparables

Compare GI Longevity with similar companies based on industry and business-model similarity.

GI Longevity comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HealthBiome Inc.
88%
Enterobiome Inc.
78%
AtoGen Co., Ltd.
78%

GI Longevity Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingNov 20, 2023
Series BJun 12, 2023

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 20, 2023

    $2.3M round led by GI Innovation Inc.

  • Jun 12, 2023

    $2M round raised

GI Longevity Filings

Explore SEC and related filing metadata, where available.

GI Longevity filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about GI Longevity's valuation, stock price, and market status.

Is GI Longevity a public or private company?

GI Longevity is a private company.

What is the current stock price of GI Longevity?

GI Longevity is a private company with no public stock price. No recent secondary market data is available.

How much is GI Longevity worth (valuation)?

Valuation information for GI Longevity is not publicly available.

Can I buy GI Longevity stock?

GI Longevity shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was GI Longevity's last funding round?

GI Longevity's most recent funding round was Corporate Funding on November 20, 2023.

Who are the main investors in GI Longevity?

Investor information for GI Longevity is not publicly disclosed.

Will GI Longevity IPO soon?

No public IPO plans have been announced for GI Longevity.

How can I track GI Longevity secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GI Longevity's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSouth Korea
Year Founded2018
Last FundingNov 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?